期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer 被引量:7
1
作者 Wei-Dong Lu Yun Zuo +1 位作者 Zhen Xu Min Zhang 《World Journal of Gastroenterology》 SCIE CAS 2015年第15期4564-4573,共10页
AIM: To investigate the mechanism by which mi R-19 a is up-regulated in gastric cancer(GC), which plays an oncogenic role.METHODS: In the present study, we investigated the role of mi R-19 a in gastric tissues as well... AIM: To investigate the mechanism by which mi R-19 a is up-regulated in gastric cancer(GC), which plays an oncogenic role.METHODS: In the present study, we investigated the role of mi R-19 a in gastric tissues as well as two GC cell lines. In vivo, we detected the basal expression level of mi R-19 a using real-time reverse transcription-PCR(RTPCR), and the relevance between expression of mi R-19 a and clinicopathological information was analyzed.In vitro, mi R-19 a was ectopically expressed using overexpression and knock-down strategies.RESULTS: Overexpression of mi R-19 a was significantly associated with metastasis of GC and inferior overall prognosis. However, no significant correlation was f o u n d b e t w e e n m i R- 1 9 a e x p r e s s i o n a n d o t h e r characteristics such as age, gender, tobacco, alcohol or tumor size. Cell proliferation, migration and invasion assays showed that overexpression of mi R-19 a promoted the proliferation, migration and invasion, and that overexpression of mi R-19 a promoted the epithelialmesenchymal transition through activating the PI3K/AKT pathway. Blocking the PI3K/AKT pathway could cancel the effect of mi R-19 a.CONCLUSION: All together, our results suggest that mi R-19 a could be used as a promising therapeutic target in the treatment of GC. 展开更多
关键词 GASTRIC CANCER miR-19a PI3K-AKT epithelialmesenchymaltransition
下载PDF
肺腺癌细胞表皮生长因子受体酪氨酸激酶抑制剂耐药相关上皮间质转化基因筛选及其调控通路分析 被引量:3
2
作者 刘文静 沈晓宇 +1 位作者 李琳琳 马锐 《临床军医杂志》 CAS 2019年第2期176-179,共4页
目的基于生物信息学方法,在肺腺癌细胞中筛选出与表皮生长因子受体-酪氨酸激酶抑制剂(EGFR-TKI)耐药、与上皮间质转化(EMT)相关的差异基因,构建蛋白互作网络,进一步筛选出枢纽基因,分析枢纽基因在肺腺癌与正常组织之间的差异表达。方法... 目的基于生物信息学方法,在肺腺癌细胞中筛选出与表皮生长因子受体-酪氨酸激酶抑制剂(EGFR-TKI)耐药、与上皮间质转化(EMT)相关的差异基因,构建蛋白互作网络,进一步筛选出枢纽基因,分析枢纽基因在肺腺癌与正常组织之间的差异表达。方法用GEO数据库中的肺腺癌细胞EGFR-TKI耐药基因表达谱芯片和EMT基因表达谱芯片共同筛选,STRING构建蛋白互作网络,MCODE分析蛋白互作网络的功能模块与枢纽基因,Oncomine分析枢纽基因在肺腺癌与正常组织之间的差异表达。结果细胞周期依赖性激酶阻滞基因1B(CDKN1B)、肌微管素相关蛋白3(MTMR3)是网络枢纽基因。CDKN1B参与有丝分裂细胞周期、苏氨酸激酶、酶复合物、P53信号通路、PI3K/AKT信号通路等调控过程; MTMR3参与磷脂酰肌醇信号通路、磷脂醇激酶、肌酸肌醇代谢等调控过程。与正常组织比较,CDKN1B在肺腺癌组织的表达降低,MTMR3在肺腺癌组织的表达升高,差异均有统计学意义(P <0. 05)。结论本研究发现了与肺腺癌细胞EGFR-TKI耐药与EMT相关的枢纽基因CDKN1B、MTMR3及其调控通路,这有助于分析肺腺癌EGFR-TKI耐药机制,寻找靶向治疗的分子标记物。 展开更多
关键词 肺腺癌 表皮生长因子受体-酪氨酸激酶抑制剂耐药 上皮间质转化
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部